MIRA Pharmaceuticals, Inc. (MIRA)
NASDAQ: MIRA · Real-Time Price · USD
0.6581
-0.0240 (-3.52%)
At close: Oct 15, 2026, 4:00 PM EDT
0.6501
-0.0080 (-1.22%)
After-hours: Oct 15, 2026, 7:43 PM EDT
MIRA Pharmaceuticals Market Cap
MIRA Pharmaceuticals has a market cap or net worth of $27.65 million as of October 15, 2026. It is the 34,591st most valuable company in the world and the 5,033rd biggest in the United States. Its market cap has increased by 10.70% in one year.
Market Cap
27.65M
Enterprise Value
19.54M
1-Year Change
10.70%
Global Rank
Country Rank
#5,033 United States
Category
ChartMarket Cap Chart
Since the IPO on August 3, 2023, MIRA Pharmaceuticals's market cap has decreased from $103.22M to $27.65M, a decrease of -73.21%. That is a compound annual growth rate of -33.72%.
| Date | Market Cap | % Change |
|---|---|---|
| Oct 15, 2026 | 27.65M | -56.27% |
| Dec 31, 2025 | 63.23M | 234.93% |
| Dec 31, 2024 | 18.88M | 21.65% |
| Dec 29, 2023 | 15.52M | -84.96% |
| Aug 3, 2023 | 103.22M | - |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Related Stocks
| Company | Market Cap |
|---|---|
| Pfizer | 161.70B |
| Bristol-Myers Squibb Company | 115.76B |
| Sanofi | 94.87B |
| GSK plc | 93.05B |
| Biogen | 33.82B |
| Grifols | 6.52B |
| Organon & Co. | 3.62B |
| Amarin Corporation | 244.60M |